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The genomic viral RNA (vRNA) segments of influenza A virus contain specific packaging signals at their
termini that overlap the coding regions. To further characterize cis-acting signals in segment 7, we introduced
synonymous mutations into the terminal coding regions. Mutation of codons that are normally highly con-
served reduced virus growth in embryonated eggs andMDCK cells between 10- and 1,000-fold compared to that
of the wild-type virus, whereas similar alterations to nonconserved codons had little effect. In all cases, the
growth-impaired viruses showed defects in virion assembly and genome packaging. In eggs, nearly normal
numbers of virus particles that in aggregate contained apparently equimolar quantities of the eight segments
were formed, but with about fourfold less overall vRNA content than wild-type virions, suggesting that, on
average, fewer than eight segments per particle were packaged. Concomitantly, the particle/PFU and segment/
PFU ratios of the mutant viruses showed relative increases of up to 300-fold, with the behavior of the most
defective viruses approaching that predicted for random segment packaging. Fluorescent staining of infected
cells for the nucleoprotein and specific vRNAs confirmed that most mutant virus particles did not contain a
full genome complement. The specific infectivity of the mutant viruses produced by MDCK cells was also
reduced, but in this system, the mutations also dramatically reduced virion production. Overall, we conclude
that segment 7 plays a key role in the influenza A virus genome packaging process, since mutation of as few
as 4 nucleotides can dramatically inhibit infectious virus production through disruption of vRNA packaging.
Influenza A virus is one of the world’s major uncontrolled
pathogens, causing seasonal epidemics as well as global pan-
demics (51). The negative-sense RNA of the influenza A virus
genome is divided into eight segments, which has important
genetic consequences for the virus. Notably, reassortment of
segments from different viruses has created at least two pan-
demic strains within the last century (52), and genome segmen-
tation may increase the stability of the genome by allowing the
purging of miscopied segments (4, 33). However, segmentation
also results in a packaging problem. Influenza virions do not
typically package more than eight segments (18, 22, 37, 39, 53).
Simplistically, incorporation of eight segments at random
would result in a small minority of viruses (around 1 in 400, or
102.6) incorporating the complete genome (37), rendering the
vast majority nonviable. Consequently, the virus has evolved a
selective packaging mechanism which ensures that virions in-
corporate one copy of each of the genomic segments (13, 16).
Packaging signals have now been defined through deletion
mapping experiments, using reverse genetics and recombinant
viral RNA (vRNA) molecules, for seven of the eight segments
(11, 12, 15, 16, 23, 35, 41). Consistent with the structure of
defective-interfering RNAs (21), these signals are generally
located toward the termini of each vRNA segment, involving
the noncoding regions but always extending some way into the
coding region.
The means by which segment packaging signals operate is
currently unclear. The favored hypothesis is that intersegment
RNA-RNA interactions build up a specific complex containing
one copy of each of the eight vRNAs (16, 36). This model is
consistent with electron microscopy (EM) studies showing that
virions tend to package eight ribonucleoproteins (RNPs)
aligned along their long axes in an array of seven around one
(18, 39, 53). However, prediction of putative interacting se-
quences is rendered difficult by the fact that vRNA molecules
are encapsidated into a helical RNP structure (29, 38, 42, 54)
and also by the possibility of non-Watson-Crick base pairing
(17). Better delineation of the signals would be useful, but this
is complicated by the overlap of cis-acting functions with open
reading frames. To address this, we previously analyzed codon
variability within the coding regions of influenza A virus and
demonstrated that variation was highly restricted in areas of
the genome known to have cis-acting functions, implying se-
lection for the primary RNA sequence as well as for the en-
coded protein (17). This information was successfully used to
predict individual functionally important nucleotides within
the packaging signals of segments 1 and 6 of the virus (17, 27).
Here we report the results of a further reverse genetic study in
which codon variation was used to investigate cis-acting RNA
functions in segment 7, the final vRNA for which no published
experimental information on packaging signals is available. We
show that synonymous changes to conserved codons, but not to
nonconserved codons, within the predicted packaging signal of
the segment drastically reduce virus fitness and produce a
consistent phenotype of defective virus assembly whose mech-
anistic details indicate a key role for segment 7 in genome
packaging.
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MATERIALS AND METHODS
Cells, virus, plasmids, and antisera. Human embryonic kidney 293T cells and
Madin-Darby canine kidney (MDCK) cells were cultured as described previously
(7). Influenza A/PR/8/34 (PR8) virus was generated using an eight-plasmid
reverse genetic system kindly donated by R. Fouchier (8). Site-directed mutagen-
esis of the reverse genetic plasmids was carried out using mismatched PCR
primers and native Pfu polymerase (Stratagene). Plasmids were sequenced using
a combination of terminal primers and (where necessary) internal primers by the
University of Cambridge Department of Biochemistry sequencing facility. Prim-
ers and PCR conditions are available on request. Plasmids pCDNA-PB1,
pCDNA-NP, and pCDNA-M1 have been described previously (34, 40). Plasmid
pCB8, containing a cDNA copy of segment 8 from the Mt. Sinai strain of PR8
cloned into plasmid pSP65 (Promega), was obtained from S. Inglis. Rabbit
anti-NP and anti-M1 sera have been described previously (2, 40), while the 14C2
anti-M2 monoclonal antibody was purchased from Abcam. Secondary antibodies
were purchased from Molecular Probes or LiCor Biosciences (fluorescent con-
jugates) or from Dako (horseradish peroxidase conjugates).
Reverse genetics and virus titrations. To produce recombinant viruses, 106
293T cells were transfected with 1 g of each plasmid and 10 l Lipofectin in
Opti-MEM (Gibco-BRL). After overnight incubation, the medium was changed
to virus growth medium (Dulbecco’s modified Eagle’s medium supplemented
with L-glutamine, penicillin, streptomycin, 1 g/ml trypsin [Worthington Bio-
chemical Corporation], and 0.14% bovine serum albumin), and the cells were
incubated for 48 h. Virus-containing supernatant was then clarified by low-speed
centrifugation (5 min at 1,000  g). To produce working stocks of virus, 0.2 ml
of each supernatant was used to infect confluent T75 flasks of MDCK cells, which
were maintained for 48 h in 15 ml virus growth medium. Additional stocks were
produced by inoculating either 100 or 1,000 PFU of virus, depending on the
experiment, into the allantoic cavity of 8-day-old embryonated chicken eggs and
incubating them at 37°C for 48 h. Segment 7 from all stocks of virus was
sequenced to confirm the presence of the desired mutations. RNAs were ex-
tracted from infected cells by use of the SV Wizard total RNA isolation system
(Promega) or from virus stocks by use of Tri Reagent LS (Sigma), reverse
transcribed using avian myeloblastosis virus reverse transcriptase (Promega) and
a terminal vRNA-binding primer, and amplified by PCR using terminal primers
and Illustra Taq DNA polymerase (GE Healthcare).
Plaque assays were carried out on confluent MDCK cells as described previ-
ously (30). For plaque size analysis, toluidine blue-stained dishes were scanned,
and ImageJ (1) was used to quantify areas of manually selected oval regions
drawn around plaques. Hemagglutination (HA) assays were carried out in 96-
well round-bottomed plates at room temperature, using 50 l of virus dilution
and 50 l of a 1% suspension of chicken red blood cells in phosphate-buffered
saline (PBS). To determine the infectious titers of stocks, cells were infected with
serial dilutions of virus and stained by immunofluorescence for NP expression at
8 h postinfection (p.i.). The proportion of infected cells in a partially infected
sample was used to calculate the multiplicity of infection, using the Poisson
formula, and hence the titer of infectious virus. To determine virus particle
number by EM, 10 l of virus was diluted 1:1 with water containing 1010 0.2-m
polystyrene latex spheres (TAAB Laboratories Equipment) and 3 g bovine
serum albumin. The mixture was adsorbed onto a glow-discharged 3-mm Form-
var-carbon-coated gold grid (TAAB Laboratories Equipment), rinsed three
times in water, and negatively stained with 2% phosphotungstic acid, pH 6.8.
Grids were imaged with a Philips CM100 transmission electron microscope.
Microscopy. For immunofluorescence, MDCK cells grown on coverslips were
processed as previously described (14). Fluorescence in situ hybridization (FISH)
was performed essentially as previously described (2). To synthesize vRNA-
binding probes, 4 g of pCDNA-PB1, pCDNA-NP, pCDNA-M1, or pCB8 was
linearized (with EcoRI for pCDNA-M1 and XbaI for the others), and RNA was
transcribed using T7 RNA polymerase (for pCDNA plasmids) or SP6 RNA
polymerase (for pCB8) in the presence of 0.25 mM cyanine 3-UTP or cyanine
5-UTP (Perkin-Elmer). Fluorescence images were captured using a Leica
TCS-NT confocal microscope. To visualize particle budding, MDCK cells were
processed as described previously (44) and then imaged with a Philips CM100
transmission electron microscope.
Protein and RNA analyses. Infected cell lysates were analyzed by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and Western
blotting according to standard procedures. Blots were imaged by chemilumines-
cence, using horseradish peroxidase-conjugated secondary antibodies and X-ray
film, or by fluorescence (for quantification), using IRDye 800-conjugated sec-
ondary antibodies on a LiCor Biosciences Odyssey near-infrared imaging plat-
form. To examine the protein content of virus particles, stocks were clarified by
low-speed centrifugation, diluted to 0.8 ml in PBS, and pelleted through a 0.5-ml
cushion of 33% sucrose in PBS, using a TLA55 rotor in a Beckman Optima
Max-E benchtop ultracentrifuge at 91,000  g for 45 min at 4°C; pellets were
resuspended in 20 l SDS-PAGE sample buffer. The vRNA content of infected
cells was determined by reverse transcriptase primer extension analysis as pre-
viously described (34). Segment 7 mRNA species were detected by reverse
transcription-PCR (RT-PCR) using an oligo(dT) primer for first-strand synthesis
followed by PCR with a primer complementary to the 3 ends of both mRNAs
and either a primer complementary to the M2 intron (for M1 mRNA) or a
primer spanning the 3 intron-exon boundary (for M2 mRNA) (5). For analysis
of the vRNA content of virus particles, 1.5-ml aliquots of clarified allantoic fluid
were pelleted through a 3-ml cushion of 25% sucrose in NTE (100 mM NaCl, 10
mM Tris, pH 7.4, 1 mM EDTA) at 103,000  g for 90 min at 4°C, using a
TLA100.3 rotor in a Beckman Optima Max-E benchtop ultracentrifuge. Pellets
were resuspended in PBS with 0.1 mg tRNA, and RNAs were extracted by
phenol-chloroform treatment followed by ethanol precipitation. RNAs were
then separated by 6% urea-PAGE and detected using a Silver Stain Plus kit
(Bio-Rad) according to the manufacturer’s instructions, except for the incorpo-
ration of a postfix oxidation step using 0.36% nitric acid (vol/vol) and 0.5%
potassium dichromate (wt/vol). Experiments in which increasing quantities of
vRNA were analyzed by this method and quantified by densitometry established
that a linear relationship existed between vRNA staining intensity and the
amount of nucleic acid over the concentration range used here (data not shown).
As an alternative means for quantitative analysis of RNA content, aliquots
(typically 150 to 300 l) of clarified virus stock were mixed with 4,600 PFU of
bacteriophage MS2, and RNAs were extracted using a QIAamp viral RNA kit
(Qiagen). RNAs were eluted in 60 l RNase-free water, and 5-l aliquots were
used to set up triplicate reactions for the detection of MS2 and either influenza
A virus segment 5 or segment 7. Detection was done by quantitative RT-PCR
(qRT-PCR), using the SuperScript III Platinum one-step qRT-PCR system (In-
vitrogen) and a Rotor-Gene 3000 real-time thermal cycler (Corbett Research
Limited), and was carried out in accordance with UK National Standard method
VSOP 25 (www.hpa-standardmethods.org.uk) for segment 7 and a derivative
protocol for segment 5. Reaction conditions, primers, and TaqMan probe se-
quences are available upon request. Data were normalized by comparison with a
dilution series of a PR8 virus of known titer; additional dilution series of the
reverse genetic plasmids for segments 5 and 7, linearized with BglI, were used as
standards to calculate the number of segments present in a sample.
RESULTS
Mutation of potential cis-acting RNA signals in segment 7
produces defective viruses. Previously, we sought to define
cis-acting RNA signals in the coding regions of the influenza A
virus genome at the nucleotide level by identifying regions of
low codon diversity (17). Mutational studies guided by these
bioinformatic data confirmed the ability of the analysis to iden-
tify conserved sequences involved in genome packaging (17,
27). These experiments primarily examined segment 1, so to
further test the applicability of our approach, we used the
bioinformatic data to guide the creation of synonymous muta-
tions in conserved coding regions of segment 7. We hypothe-
sized that such regions were likely to contribute to functionally
important RNA elements. Attention was directed at the ter-
minal regions of the segment (Fig. 1A) because although no
prior experimental data on segment 7 packaging signals were
available, extrapolation from the other seven segments (11, 12,
15, 16, 23, 35, 41, 50) suggested a likely role in genome pack-
aging. Eight mutants were designed; half had changes to evo-
lutionarily conserved codons, and half had changes in nearby,
nonconserved codons as controls. The maximum number of
synonymous changes (between two and five point mutations)
was introduced into two or three adjacent conserved or non-
conserved codons (Fig. 1B).
Although the bioinformatic analysis aimed to identify novel
functional RNA sequences, it also identified known cis-acting
sequences, such as splice donor and acceptor sequences (17).
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In general, the mutations were placed so as not to affect pre-
viously identified RNA functions. The exception to this was M1
V7-T9, where the mutations overlapped the 5-splice donor of
M2, altering the normally invariant G immediately 3 of the
splice site (Fig. 1B), a change expected to block splicing. Loss
of M2 function is debilitating but not fatal to virus growth in
tissue culture (5, 45, 49); thus, the M1 V7-T9 virus was ex-
pected to provide a baseline with which to gauge the severity of
any defects resulting from the other mutations.
Mutations were introduced into a reverse genetic cDNA
clone of PR8 segment 7 (8), and wild-type (WT) and mutant
viruses were rescued by transfection of plasmids encoding this
and the other seven segments into 293T cells. To assess the
growth parameters of the viruses, stocks of the rescued viruses
were grown in MDCK cells and titrated by plaque assay. Sev-
eral independently rescued isolates of WT PR8 virus grew to
titers of around 108 PFU/ml (Table 1). Mutant viruses with
alterations to nonconserved codons replicated to very similar
levels to those of the WT virus (plotted graphically in Fig. 2A;
actual titer values are given in Table 1). However, viruses with
alterations to conserved codons grew markedly less well, re-
leasing between 10-fold (M2 H90-V92) and nearly 1,000-fold
(M1 G18-L20) lower titers of PFU than the WT virus (Fig.
2A). Mutation of conserved codons also resulted in a statisti-
cally significant (P 0.001) small-plaque phenotype in MDCK
cells (Fig. 2B). To test for the presence of defective virions able
to initiate a single but not multiple rounds of infection (as, for
instance, might be expected if segment 7 were missing [28]),
the infectious titers of the viruses were measured according to
the ability of the viruses to express detectable levels of NP in
individual cells at 8 h p.i. However, with one exception, the
relative reductions in the ability of viruses with mutations in
conserved regions to cause a single round of infection were
similar to the relative reductions in their plaque titers (Fig.
2A). In the case of M1 V7-T9, the infectious titer was slightly
greater than the plaque titer, but this was not statistically
significant. The quantity of virus particles produced from in-
fected cells was measured by HA assay. For viruses with mu-
tations in conserved codons, this demonstrated relative growth
defects similar to those observed by the plaque titers, again
with the exception of M1 V7-T9, where the relative HA titer
was slightly higher than the plaque titer (Fig. 2A). Together,
these data show that synonymous changes to nonconserved
codons in segment 7 have little effect on virus replication, but
mutations in conserved regions are markedly deleterious to
virus growth, lowering the output of infectious virus particles.
To examine the phenotypes of the mutants in a more phys-
iological system, virus growth was assayed in embryonated
chicken eggs. In this setting, the M1 E23-A25 mutant with
changes to nonconserved codons grew similarly to the WT
virus, whether replication was assessed by plaque, infectious,
or HA titer (Fig. 2C and Table 2). The four viruses with
alterations to conserved sequences showed similar drops in
plaque titer relative to the WT virus to those for growth in
MDCK cells, confirming their growth-defective phenotype.
However, in contrast to their behavior in tissue culture, the
relative infectious titers (as measured by the ability to express
NP in a single cell) of the egg-grown defective viruses were
substantially different from their relative plaque titers, display-
ing around 10-fold higher values (Fig. 2C). Additionally, the
relative defects in particle release of these viruses (as mea-
FIG. 1. Mutation of putative cis-acting signals in segment 7.
(A) Scale diagram of segment 7 open reading frames and locations of
introduced mutations in conserved codons (pointed arrows) and non-
conserved codons (rounded arrows). (B) Nucleotide sequences (plus
sense) of the codons altered in the indicated viruses. Mutations are
shown in lowercase bold letters, and the mutant (Mut) and WT se-
quences are given. Also shown are the mean pairwise difference scores
for each codon on a scale where 0 corresponds to absolute conserva-
tion of the codon and 1 corresponds to no conservation beyond that
expected from amino acid constraint (17). The line in M1 V7-T9
indicates the position of the M2 splice site.
TABLE 1. Plaque titers of MDCK-grown viruses
Virus
Titer (PFU/ml) in expt:
1 2 3 4 5
WT 3.8  107 7.3  108 6.2  108 2.6  108, 8.8  108 3.0  108
M1 V7-T9 1.1  106, 2.0  106 2.8  104
M1 G18-L20 4.2  106 4.8  104 4.3  104
M2 S71-R73 1.2  106 3.1  107 8.0  106
M2 H90-V92 7.5  107 1.1  107
M1 I15-P16 5.5  108, 5.2  108
M1 E23-A25 6.6  108 4.0  108
M2 E75-R77 6.0  108, 3.5  108
M2 R77-K78 5.8  108, 6.2  108
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sured by HA titer) were slight (10-fold) compared to the
particle release of the WT virus (Fig. 2C). To gain a more
precise measure of virion production, the titer of released virus
particles in the allantoic fluid was determined directly by par-
ticle counting (Fig. 2C). The particle counts were in good
agreement with the HA assay data and confirmed that the
defects in particle release were of a lesser magnitude than
those observed in the matching plaque titers. In combination
with the plaque assay data, we calculated particle/PFU ratios.
The value for WT virus averaged around 40, in agreement with
earlier studies (10, 43), while the control virus with mutations
to nonconserved codons performed similarly (Fig. 2D). How-
ever, all four viruses with synonymous mutations in conserved
terminal coding regions of the segment had particle/PFU ratios
that were increased between 25- and 300-fold (Fig. 2D). Se-
quencing of segment 7 from each of the WT and mutant virus
preparations from MDCK cells and eggs showed the presence
of the designed mutations and no evidence of additional mu-
tations (data not shown). Thus, synonymous mutations to con-
served codons in the terminal regions of segment 7 caused
defective viral growth in cell culture and in embryonated eggs,
although the phenotypes of the viruses differed between the
two systems. Growth in MDCK cells led to reduced amounts of
released virus, while growth in eggs had less effect on the
quantity of virus particles formed but dramatically reduced
their specific infectivity.
Effects of mutations on viral gene expression and RNA syn-
thesis. With the exception of M1 V7-T9, which interferes with
the 5-splice donor site of M2, it was not anticipated that any
FIG. 2. Growth characteristics of viruses with mutations in the terminal coding regions of segment 7. Virus stocks were grown by low-
multiplicity infection of MDCK cells (A and B) or eggs (C and D); viruses with changes to conserved codons are indicated by horizontal bars. (A
and C) Virus growth was assessed by plaque assay, infectious center assay, HA assay, or EM particle counting (C and D). Values are plotted relative
to the titer achieved by the WT virus in each experiment. The means plus standard deviations (SD) for three independently rescued virus stocks
(for plaque and infectious titers of MDCK-grown M1 V7-T9, M1 G18-L20, and M2 S71-R73) or the means plus half-ranges for two virus stocks
(for all other conditions) are shown. (B) Plaque size in MDCK cells was quantified and plotted relative to the mean area ( SD) produced by
infection with WT virus. Between 28 and 212 plaques were counted (mean, 93 plaques), depending on the virus. (D) The particle titers of
egg-grown virus stocks were established by EM and used to derive particle/PFU ratios. The means plus half-ranges for two independent
experiments are plotted.
FIG. 3. Effects of synonymous mutations on viral mRNA synthesis.
Total cell RNA was isolated from MDCK cells infected (or mock
infected) with the indicated viruses at an MOI of 1 at 8 h or 22 h p.i.,
and M1 (A) or M2 (B) mRNA was detected by RT-PCR followed by
agarose gel electrophoresis and staining with ethidium bromide. Wa-
ter, PCRs carried out without a template.
TABLE 2. Plaque titers of egg-grown viruses
Virus
Titer (PFU/ml) in expt:
1 2
WT 1.8  109 1.3  109
M1 V7-T9 1.1  107 2.5  105
M1 G18-L20 7.5  106 5.0  105
M2 S71-R73 5.5  107 9.4  106
M2 H90-V92 8.0  107 3.7  107
M1 E23-A25 9.0  108 7.5  108
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of the mutations would directly affect RNA or protein expres-
sion. Nevertheless, to control for possible pleiotropic effects,
viral macromolecular synthesis was examined. To analyze seg-
ment 7 mRNA synthesis, RT-PCR analysis was carried out on
total RNA isolated from cells infected with WT or defective
virus and harvested at 8 h or 22 h p.i. Similar quantities of M1
mRNA were detected for most viruses (Fig. 3A). One possible
exception was the M2 H90-V92 virus, which in some, but not
all, experiments displayed a slight reduction in M1 mRNA
(Fig. 3A, lanes 9 and 10). M2 mRNA was also produced nor-
mally in cells infected with all viruses, with the expected ex-
ception of M1 V7-T9, in which no expression was detectable
(Fig. 3B). To assess viral protein synthesis, infected cell lysates
were first examined by Western blotting. For all mutant vi-
ruses, M1 and NP proteins accumulated in infected cells at
levels similar to those in WT virus (Fig. 4A). M2 expression
was detected by immunofluorescence staining of infected cells,
revealing similar intensities of staining for all viruses except
M1 V7-T9, where no M2 was detectable, despite counterstain-
ing for NP indicating successful infection (Fig. 5).
Next, we examined the effects of the mutations on vRNA
synthesis. Relatively small amounts of vRNA (either segment 5
or 7) were detected in samples collected at 8 h p.i. from cells
infected with the WT virus, while as expected, the quantities of
both vRNAs had increased considerably at 22 h p.i. (Fig. 6A,
lanes 1 and 2). No significant alteration to this pattern was seen
with the defective viruses M1 V7-T9, M1 G18-L20, and M2
S71-R73 or the control virus M1 E23-A25 (Fig. 6A, lanes 3 to
8, 11, and 12). However, although exhibiting normal synthesis
of segment 5, the M2 H90-V92 virus showed a consistent
failure to amplify segment 7 vRNA at the late time point (Fig.
6A, lanes 9 and 10). In replicate experiments, accumulation of
segment 7 (but not segment 5) vRNA was reduced about
fivefold compared to that for the WT virus (Fig. 6B). Thus, the
introduction of synonymous mutations into the conserved ter-
minal coding regions of segment 7 had no effect on viral mac-
FIG. 4. Effects of synonymous mutations on M1 and NP expression and incorporation into virions. (A) Lysates from MDCK cells infected (or
mock infected) at an MOI of 1 with the indicated viruses and harvested at 24 h p.i. were analyzed by SDS-PAGE and Western blotting for NP
or M1, as labeled. (B) Approximately 1 109 virus particles from infected eggs were pelleted through a sucrose cushion, resuspended, and analyzed
by SDS-PAGE and Western blotting for NP and M1. (C) The ratio of NP to M1 protein in two independently rescued egg-grown virus stocks was
determined by densitometry of Western blots. Mean plus half-range values normalized with respect to those of WT virus are plotted; the bar
indicates viruses with changes to conserved codons.
FIG. 5. M2 expression in WT and mutant virus-infected cells. MDCK cells were infected with the indicated viruses (or mock infected) at an
approximate MOI of 1, fixed at 8 h p.i., and stained for M2 (green) and NP (red) by immunofluorescence.
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romolecular synthesis for the M1 G18-L20 or M2 S71-R73
mutant, while as expected, the M1 V7-T9 mutant failed to
produce M2 mRNA and protein. Unexpectedly, M2 H90-V92
showed selectively reduced accumulation of segment 7 vRNA
as well as possibly a minor decrease in the synthesis of segment
7 mRNA.
Synonymous mutations in segment 7 lead to defects in
virion assembly. All four viruses with synonymous mutations in
the conserved terminal coding regions of segment 7 showed
significant growth defects in tissue culture and in eggs. In the
case of M1 V7-T9 virus, this could plausibly be ascribed to its
failure to express M2, while for M2 H90-V92, the reduction in
segment 7 vRNA levels might play a role. However, the mo-
lecular basis for the poor replication of the M1 G18-L20 and
M2 S71-R73 viruses was less obvious. To investigate the effects
of the mutations on virion release, MDCK cells were infected
at a high multiplicity, fixed at 8 h p.i., and imaged by transmis-
sion EM (Fig. 7A). For WT and M1 E23-A25 viruses, virions
were seen budding in abundance from the plasma membranes
of infected cells; with the defective mutants, budding viruses
appeared to be less profuse. Although not quantitative, this
confirms the inference from the HA titer data that viruses with
mutations in conserved regions release fewer virions from in-
fected MDCK cells and indicates that this was not due to a
failure of assembled virions to detach from the plasma mem-
brane. However, where virions were produced, they did not
show obvious exterior morphological defects (Fig. 7A, insets)
and in some cases showed the presence of dark staining in the
virion interior indicative of RNPs (39). However, in our hands,
the frequency of particles that clearly showed the distinctive
71 array of RNPs seen by other investigators (18, 39, 53) was
not sufficiently high even in WT virus preparations to permit a
numerical analysis of the content of mutant virions. EM of
virion production from the chorioallantoic membranes of eggs
was not attempted, but negative staining of virions found in the
allantoic fluid showed them to also have apparently normal
exterior morphology (Fig. 7B).
As the rationale of our study was to examine segment 7
packaging signals, we next examined the genome content of the
egg-grown virus stocks. This was first assessed by measuring
the amount of NP protein incorporated into virions. Egg-
grown viruses were pelleted from allantoic fluid, and the pro-
tein contents of approximately equal numbers of particles
(normalized by M1 content) were analyzed by Western blot-
ting. The amounts of NP incorporated into three of the defec-
tive viruses were considerably smaller than that found in WT
or control viruses (Fig. 4B). When the ratio of NP to M1 was
measured from two independent sets of virus stocks, it was
decreased around sixfold in the case of M1 V7-T9 virus and
around three- to fourfold for the M1 G18-L20 and M2 S71-
R73 viruses (Fig. 4C). NP is the major protein component of
RNP complexes (42), so for these viruses, a lack of NP implies
a reduction in total genome content.
To detect genomic RNA directly, virus was pelleted from
allantoic fluid, and vRNAs were extracted and quantified by
qRT-PCR for segments 5 and 7. In combination with DNA
standards of known concentrations and the previously deter-
mined particle titers of the viruses, this allowed the determi-
nation of the average number of segments per virion. The
values so calculated for WT virus were around 5 copies per
particle (data not shown), in reasonable agreement with the
expected value of 1; the discrepancy probably reflects system-
atic errors in the particle counting process and/or qRT-PCR
quantification. Accordingly, the values obtained for the mutant
viruses were normalized with respect to WT virus levels. For
the control virus M1 E23-A25, with mutations to nonconserved
codons, the values obtained were close to those for the WT
virus (Fig. 8A). In contrast, the three most defective viruses
with alterations to conserved codons had substantially fewer
copies of each segment per particle than WT virus did, with the
number of copies of each segment incorporated by M1 V7-T9
being less than 1/10 of WT levels and M1 G18-L20 and M2
S71-R73 containing around 1/3 of the WT number of segments
(Fig. 8A). The M2 H90-V92 virus also showed a reduction in
vRNA content compared to the WT virus, but this was less
than those for the other mutants. In all cases, however, it was
noticeable that although the mutations were introduced into
segment 7, incorporation of segment 5 was also reduced pro-
portionally. To determine if this was matched by similar re-
FIG. 6. Effects of synonymous mutations on vRNA synthesis.
(A) vRNA contents of total RNAs isolated at 8 or 22 h p.i. from
MDCK cells infected (or mock infected) with the indicated viruses at
an MOI of 0.5 were determined by reverse transcriptase primer exten-
sion with oligonucleotides specific for segments 5 and 7. (B) Segment
5 and 7 vRNA accumulation at 22 h p.i. from WT and M2 H90-V92
viruses was quantified by densitometry. Means plus SD (for five inde-
pendent experiments) are plotted relative to levels in WT virus-in-
fected samples. (C) Expression of individual vRNAs in single infected
cells. Cells were infected with the indicated viruses at an empirically
determined dilution that resulted in not all cells expressing NP, fixed at
12 h p.i., and stained by immunofluorescence for NP and by FISH for
either vRNA segments 7 and 2 or 5 and 8 (see the legend to Fig. 9 for
further details). Cells were scored for the percentage of infected cells
(defined as expressing NP protein) that failed to also express one or
more of the vRNA segments stained by FISH. Data are plotted as
means plus SD for four experiments, two stained for segments 2 and 7
and two stained for segments 5 and 8.
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ductions in the contents of the other six segments, we exam-
ined the RNA content of virions directly by urea-PAGE and
silver staining. When RNAs were extracted from equal num-
bers of virus particles, the overall amounts obtained from the
viruses with mutations to conserved codons (as determined by
densitometry) were reduced over sevenfold for virus M1 V7-T9
and three- to fourfold for the other three viruses, confirming
the lower yields seen by qRT-PCR. However, when the RNA
samples were normalized before PAGE analysis to take this
into account, RNA species with the expected relative mobili-
ties for the full complement of eight vRNA molecules were
visible at similar staining intensities in all cases, i.e., from WT
virus, the phenotypically normal M1 E23-A25 mutant, and the
four defective viruses (Fig. 8B, lanes 1 to 6). A sample derived
from an equivalent quantity of uninfected allantoic fluid was
devoid of any apparent staining (lane 7). Thus, no individual
segment appeared to be lost specifically from any of the mutant
viruses. Densitometry of replicate gels indicated no more than
a twofold deviation from apparent equimolar packaging (data
not shown), suggesting that the matching reductions in pack-
aging of segments 5 and 7 seen by qRT-PCR were indeed
accompanied by similar reductions of all genome segments.
As an alternative method of assessing the specific infectivity
of the viruses, independent of EM particle counting, the qRT-
PCR data were plotted with reference to the plaque titers of
the virus stocks, thus displaying the relative numbers of input
FIG. 7. EM analysis of virus budding and assembly. (A) MDCK cells were infected (or mock infected) with the indicated viruses at an MOI
of 4 and fixed at 8 h p.i. before analysis by transmission EM. Bar, 500 nm. Insets show individual virions at an increased magnification.
(B) Egg-grown virus was purified and examined by negative stain transmission EM. Representative virions are shown.
FIG. 8. Effects of synonymous mutations on segment packaging. (A and C) RNAs were extracted from the allantoic fluid of infected eggs or
the culture medium of infected MDCK cells, and segment 5 and 7 vRNA contents were determined by qRT-PCR. Segment concentrations were
calculated with respect to plasmid standards. (A) The matching particle titers (Fig. 2) were used to calculate segment/particle ratios that were then
normalized with respect to that seen for the WT virus. The mean plus half-range values for two independently rescued virus stocks are shown.
(B) Egg-grown virions were pelleted from infected allantoic fluid, and approximately equal amounts of RNA (corresponding to approximately 6 
109 WT virus particles) were separated by urea-PAGE and detected by silver staining (lanes 1 to 6). Mock-infected allantoic fluid was analyzed
in parallel (lane 7). (C) Plaque titer data (Fig. 2) were used to calculate the segment/PFU ratios of the indicated viruses. Values were normalized
to those of the WT egg-grown virus. The means and half-ranges for two independently rescued virus stocks are shown (except for MDCK-grown
WT virus, for which the mean and SD for three independent isolates are plotted).
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segments needed to successfully initiate a plaque. Values for
the WT and control M1 E23-A25 viruses (grown in eggs) were
similar (Fig. 8C, left panel). The defective virus stocks, how-
ever, packaged between 10- and 100-fold larger numbers of
segments for each PFU (Fig. 8C), confirming their dramati-
cally increased particle/PFU ratios (Fig. 2D). We were unable
to get reliable particle counts for the mutant virus stocks grown
in MDCK cells because in this system the defective viruses
released far fewer particles than the WT virus did (Fig. 2A).
However, the better sensitivity of the qRT-PCR method al-
lowed the measurement of segment/PFU ratios for these vi-
ruses. Like the case for those grown in eggs, the three most
defective viruses showed notable increases in the numbers of
segments required to initiate a multicycle infection compared
to fully replication-competent viruses, although these increases
were not as high as those for the egg-grown viruses (Fig. 8C,
right panel). Thus, although the primary effect of the segment
7 mutations on virus growth in MDCK cells was to inhibit
particle assembly, those virions that were formed also had a
lower specific infectivity than that of WT virions, similar to the
mutant phenotype in eggs.
Thus, synonymous mutations within conserved segment 7
coding regions led to packaging defects in which the popula-
tions of mutant particles contained lower than expected but
approximately equimolar quantities of each segment. How-
ever, in relative terms, the underincorporation of the genome
was slight compared to the magnitudes of the deficits in overall
virus replication and particle/PFU or segment/PFU ratios, i.e.,
there were approximately 3- to 10-fold reductions in genome
content (Fig. 8A) versus 10- to 400-fold changes in plaque
titers (Fig. 2C) and particle/PFU ratios (Fig. 2D) or segment/
PFU ratios (Fig. 8C). To explain this, we hypothesized that the
mutations disrupted the packaging mechanism to such an ex-
tent that a minority of virions contained one copy of all eight
segments and the majority contained an imperfect selection
with a mean number of substantially less than 8. To test this
hypothesis, we infected cells at a low MOI and at 12 h p.i.
examined their ability to successfully express NP protein by
immunofluorescence and to amplify pairs of vRNA segments
by FISH. The latter step requires the presence of genes for the
three polymerase proteins and NP (the minimal requirements
for genome replication) (19, 47) as well as whatever additional
segments are under analysis. Expression of NP protein re-
quires only the presence of segment 5, as primary mRNA
transcription produces substantial amounts of gene expression
even in the absence of vRNA amplification (2, 7, 25). In cells
infected with WT virus, most cells that expressed detectable
levels of NP protein also contained substantial quantities of
segments 2 and 7 that, as expected for a late time point, were
predominantly cytoplasmic (Fig. 9A). Even with WT virus,
however, some cells were apparently abortively infected and
contained only NP protein that was retained in the nucleus
FIG. 9. FISH analysis of vRNA content of individual infected cells. MDCK cells were infected with the indicated viruses at an empirically
determined dilution that resulted in not all cells expressing NP. Cells were fixed at 12 h p.i. and stained by immunofluorescence for NP (green)
and by FISH for segments 7 (red) and 2 (magenta). Nuclei were stained with DAPI (4,6-diamidino-2-phenylindole) (blue). Open arrowheads
highlight cells expressing only NP protein, filled arrowheads show those expressing NP and a single vRNA, and arrows show cells expressing NP
and both vRNAs, but with nuclear export failing to occur.
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(Fig. 9A). However, in cells infected with either of the two
most defective viruses, infected cells that stained positively for
all three viral macromolecules were in the minority. The ma-
jority contained nuclear NP staining with either no detectable
vRNA (Fig. 9B and C), only a single segment, or both vRNAs
retained in the nucleus, indicating an abortive infection for
other reasons. Essentially identical results were obtained when
cells were stained for NP and vRNAs for segments 5 and 8
(data not shown). When individual NP-expressing cells from
replicate experiments were scored according to whether infec-
tion had proceeded normally, with evident expression of both
vRNAs under examination, it was apparent that the mutant
viruses initiated a far larger proportion of abortive infections
that failed to detectably express one or more vRNA molecules
(Fig. 6C). This behavior is consistent with the hypothesis that
the synonymous mutations in segment 7 disrupt packaging to
the extent that significant numbers of infectious but defective
particles containing an incomplete genome are formed.
DISCUSSION
Having previously identified regions of codon conservation
in the influenza A virus genome (17), we show here that in-
troducing even a small number of synonymous changes into
such regions of segment 7, in an otherwise WT background,
renders the virus profoundly defective. The mutations chosen
did not substantially increase the use of codons that are rare in
influenza A virus genomes (17) or canine and chicken genomes
(http://www.kazusa.or.jp/codon/) or the number of unfavorable
codon pairs (6). We aimed to define segment-specific packag-
ing signals, and the consistent outcome of a phenotype of
poorly infective particles with defects in vRNA content sug-
gests that we were successful. Segment 7 was (to the best of our
knowledge) the last influenza A virus genomic segment for
which no published experimental information was available
regarding the presence or location of packaging signals, either
from direct mapping experiments or inferred from the struc-
ture of defective interfering RNAs. Although our mutational
strategy was not exhaustive, the fact that mutations located in
the terminal coding regions disrupted packaging, coupled with
our previous bioinformatic approach (17), strongly suggests
that like all other segments, segment 7 contains packaging
signals located toward the 5 and 3 ends of the vRNA coding
regions.
With the exception of a mutation expected to disrupt the 5
splice donor site for the M2 mRNA (M1 V7-T9), none of the
alterations targeted RNA sequences with known function.
However, two of the mutants had phenotypes suggestive of
pleiotropy. The M1 V7-T9 virus replicated poorly (Fig. 2) and
had the most severe packaging defect in terms of its segment/
particle ratio (Fig. 8A), and while this is consistent with other
work showing the importance of M2 for particle assembly and
genome packaging (20, 31, 32), we suspect that the lack of M2
was not the only defect at play. Supporting this, an MDCK cell
line that constitutively expresses M2 (46) did not complement
the growth of M1 V7-T9 virus, whereas growth of a virus whose
M2 expression was abolished by stop codons in exon 2, well
away from the segment termini, was increased 10,000-fold
(data not shown) (M2 virus and MDCK-M2 cells were a kind
gift from W. Barclay). Thus, it appears that this small region of
RNA fulfils at least four separate but overlapping roles, as part
of an open reading frame for two proteins, as a splice donor
site, and as a packaging signal. In further evidence of pleiot-
ropy, the M2 H90-V92 virus was unexpectedly and specifically
deficient in the accumulation of segment 7 vRNA. The reason
for this deficiency is unknown. It could in principle be due to a
defect in segment 7 vRNA or cRNA synthesis or to a reduction
in the stability of either RNA species. Although mutations in
the unique regions of segments have previously been shown to
affect vRNA synthesis (3, 55), these alterations were in the
untranslated regions and closer to the core promoter se-
quences than those in virus M2 H90-V92, which are a further
15 to 21 nucleotides in from the untranslated region. This is
similar to the behavior of two synonymous point mutations in
a segment 1-derived reporter construct that reduced vRNA
accumulation in a mini-replicon system between three- and
fivefold, despite lying nearly 60 nucleotides into the coding
region (17). In all of these cases, the lowered accumulation of
the mutant segments did not affect the efficiency with which
they were packaged into virus (3, 17), and in counterpoint, it
seems unlikely that the reduced accumulation of segment 7 in
the M2 H90-V92 virus is the only reason for its poor replica-
tion. Although it was the least severely affected virus, like the
other three viruses with alterations to conserved codons, it also
showed increased particle/PFU and segment/PFU ratios and a
decrease in overall packaged vRNA content, suggesting that it
too has a packaging defect. Thus, it is plausible that there are
multiple overlapping RNA functions in this mutated region as
well. Overall, these data highlight the functional complexity of
the influenza virus genome.
Experiments utilizing deletion mapping studies of the up-
take of engineered reporter vRNA molecules provide compel-
ling evidence that segment-specific packaging signals exist but
have not elucidated the means by which they function (9, 11,
15, 16, 23, 35, 41, 50). Like others, we reasoned that studying
the behavior of otherwise normal viruses with synonymous
lesions in individual segments that specifically affected segment
packaging would be informative. So far, studies have applied
this strategy to segments 1 to 4 and 8 (15, 24, 26, 27). It is
therefore interesting to compare our results for segment 7 with
these prior data. One strikingly consistent finding is that rela-
tively small changes to packaging signals (in many cases with
no evidence of nonspecific effects on other aspects of virus
replication) can profoundly inhibit virus replication. Reduc-
tions in titer to 0.1 to 1% of WT levels resulted from synony-
mous alterations of between 3 and 14 nucleotides in segment 7
(virus M1 G18-L20 [this study]) and in segments 1 to 3 (24, 27).
Indeed, in our hands, mutation of as few as four nucleotides
within segment 7 caused as profound a defect in virus replica-
tion as the loss of M2 expression. Other changes within these
segments or within segment 4 or 8 had lesser effects but still
reduced virus replication up to 10-fold (15, 26). The effect of
mutating a particular segment on packaging of it and the other
segments was less consistent, however. Most mutations to seg-
ments 1 to 3 that reduced overall virus replication also resulted
in nonequimolar packaging of the vRNAs, with disproportion-
ate reductions (for segments 1 and 2) in the packaging of the
mutated segment (27). In the case of segment 1, many (but not
all) mutations also substantially reduced packaging of all seg-
ments except for segments 4 and 6 (27). When segment 3 was
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mutated, incorporation of segments 1 and 5 was apparently
more affected than that of segment 3 itself (27). In contrast,
mutation of packaging signals in segments 4 and 7 had little
effect on the stoichiometry of segment incorporation into the
virus population, with generally 2-fold changes in the pro-
portion of any individual segment (26 [segment 4]; this study
[segment 7]). Marsh and colleagues did not examine the num-
bers of particles formed by their mutant viruses, but we show
here that the apparently equimolar vRNA incorporation in the
presence of a mutated segment 7 in fact resulted from a re-
duction in packaging of all eight segments (Fig. 8A). The
observation that WT virus particles do not commonly incorpo-
rate more than eight vRNAs (22, 37, 39), in conjunction with
the relative reductions in genome content of the mutant vi-
ruses, strongly suggests that, on average, the viruses contained
substantially fewer than eight segments per particle, consistent
with the evident lack of one or more vRNAs in the majority of
cells infected by the M1 V7-T9 and M1 G18-L20 viruses (Fig.
6C and 9). Interpreting this result in light of the prevailing
hypothesis that packaging signals operate by mediating a web
of specific intersegment RNA-RNA interactions that assemble
a tightly apposed array of all eight vRNAs (16, 17, 39) suggests
that segment 7 plays a major role in this process because
mutations to a single segment have disrupted packaging of
most, if not all, segments. In the case of the M1 V7-T9 and M1
G18-L20 viruses, the severity of the packaging defect is such
that the increases in particle/PFU ratio relative to that of the
WT virus approach that predicted for a purely random pack-
aging process (22, 37) (around 2 log10 worse than that of the
WT virus). Other possibilities, such as pseudo-random pack-
aging resulting from incorporation of specific subcomplexes of
segments that, in aggregate, appear equimolar, are also com-
patible with the data. Based on the efficiency with which hybrid
reporter vRNA constructs supported the formation of virus-
like particles, Muramoto and colleagues concluded that seg-
ment 1 exerted a particularly important influence on packaging
of other segments (35). We note, however, that if one considers
the small numbers of virus-like particles formed in their ex-
periments in the absence of segment 7 or any likely segment 7
packaging signals, the data suggest an equal importance for
segment 7, consistent with our findings. It may be that further
analyses of this type, applied to other segments, will permit a
fuller model of these putative segment interactions to be built
up. Ultimate confirmation (or refutation) of the RNA-RNA
interaction model for packaging will, however, require other
experimental approaches.
Several studies have noted that the loss of an individual
segment or the deletion of functionally important regions of its
packaging signals reduces the number of particles released
from cultured cells (9, 16, 23, 35). We confirmed and extended
this observation by showing that mutation of as few as four
nucleotides is sufficient to inhibit particle formation from
MDCK cells by over 99% (Fig. 2A). For the mutants described
here, it is notable that viral proteins were synthesized normally
in infected MDCK cells, yet there was no evidence for an
accumulation of virions that were stalled at the plasma mem-
brane due to a defect in the pinching-off process (as seen, for
example, during lipid raft perturbation [48]). One possibility,
therefore, is that assembly of a higher-order RNP complex
somehow promotes the budding process in mammalian cells.
Interestingly, however, the inhibitory effect of the packaging
mutations on virus budding was far less marked when the
viruses were grown in embryonated eggs, with particle or HA
titers decreasing 10-fold (Fig. 2C). Although the production
of viable virus particles by the mutants was equally low in the
two systems, the tendency in eggs was to produce greater
numbers of defective particles than those produced from cul-
tured cells (Fig. 2A and C and 9C). Comparison of published
results (9, 16, 23, 35) indicates that reduced levels of virus
budding in the absence of normal packaging signals are con-
sistent for at least MDCK and 293T cells, but we have not yet
tested whether the altered behavior of our mutants in eggs is
specific to the tissue used or reflects a general feature of avian
cells. We previously suggested that incompatibilities between
packaging signals from different strains of virus will influence
the process of genome reassortment (17). The finding here that
small sequence alterations can profoundly affect virus fitness is
consistent with this hypothesis. The possibility that cell type or
species also affects the process of virus reassortment has sig-
nificant implications for influenza A virus evolution and is
worth investigating further.
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